Events & Presentations Upcoming Events No upcoming events at this time Past Events SVB Securities Virtual Global Biopharma Conference 2023 Feb 16, 2023 at 2:20 PM EST Click here for webcast Investor Presentations ARS Pharmaceuticals - Corporate Presentation ARS Pharmaceuticals - Corporate Presentation 5.9 MB Scientific Presentations ACAAI 2022 Poster 006 Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB AAAAI 2020 Poster 022 Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB ACAAI 2022 Poster 237 ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB AAAAI 2022 Poster 008 Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB Pagination First page « first Previous page ‹ previous Page 1 Current page 2
Investor Presentations ARS Pharmaceuticals - Corporate Presentation ARS Pharmaceuticals - Corporate Presentation 5.9 MB Scientific Presentations ACAAI 2022 Poster 006 Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB AAAAI 2020 Poster 022 Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB ACAAI 2022 Poster 237 ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB AAAAI 2022 Poster 008 Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB Pagination First page « first Previous page ‹ previous Page 1 Current page 2
Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use: A Patient/Caregiver Survey 1.3 MB
Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions 787.7 KB
ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic Differences and Differential Affinities for Adrenergic Receptors 3.4 MB
Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB
